Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

The antitumor activity of cis-diamminedichloroplatinum II (cisplatin) is believed to be related to its covalent interaction with DNA where a major DNA binding product is an intrastrand N7-bidentate adduct on adjacent deoxyguanosines. A novel immunoassay was used to quantitate this adduct in buffy co...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Reed, E, Yuspa, S H, Zwelling, L A, Ozols, R F, Poirier, M C
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1986
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC423377/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3944268/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI112335
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!